- Another Johnson & Johnson Drug Manufacturing Plant Cited for Safety Failures
- FDA Dysfunction Leaves Avandia-Taking Patients to Watch Out for Their Own Safety
- Johnson & Johnson, McNeil Drugs Continue to Be Investigated and Recalled for Safety
- Yaz - Getting the Word Out
- Effexor XR to go Generic
- More Evidence Emerges of Increased Risk of Death and Disability From Avandia
- Paxil - Future Cases
- Reglan - No News?
- Reglan - the Reason for the Cases
- Yaz - Gianvi Labeling Woes
- Drug Used for Endometriosis and Prostate Cancer Linked With Misery for Patients
- Couple Files Reglan Suit
- Yaz: What is a Pulmonary Embolism?
- Paxil: Ethical Concerns
- Reglan: Tardive Dyskinesia Side Effects — You Can't Stop Them
- Levaquin - Varied Reactions
- Effexor - Living with PPHN
- Consumer Reports Warns Bone-Strengthening Drugs May Actually Cause Fractures
- Yaz: Something Wicked
- Yaz: What a Stroke Means
- FDA and House of Representatives Launch Investigations Into McNeil Recall
- Yaz: What You Don't Know
- Cymbalta and Birth Defects
- FDA Says Popular Acid Reflux Drugs Pose Risks of Fractures and Infection
- USA Piles on Pills
- Lexapro and PPHN
- Paxil Progressively Problematic
- Lupin Loses Levaquin Generic Fight
- FDA Cracks Down on Company Making Medications Contaminated With Insect Parts
- Paxil to be Tested on 7-year-olds
- Schwarz Found Not Responsible in Texas Reglan Case
- Beyond Clots - Yasmin and Gallbladder Symptoms
- FDA Slaps Black Box Warning on Hyperthyroidism Drug for Causing Severe Liver Damage
- Pharmaceutical Compliance Cops to Ride Along With Sales Reps
- Levaquin Lawsuits Moving Forward Slowly
- The Controversy of Yaz and Yasmin
- FDA and Congress Investigate Contamination and Other Problems at Johnson & Johnson
- Reglan Used for Infants
- FDA Rebukes Teva Pharmaceutical for Lax Manufacturing Practices
- Avandia Study May End Early Due to High Risk of Patient Heart Attack
- FDA Reprimands Drug Companies for Misrepresenting Drugs’ Safety
- Study Links Epilepsy and Depression Drugs to Suicidal Thoughts and Attempts
- Drug Manufacturer Admits It Ignored Duty to Warn FDA of Its Defective Products
- FDA Warns Patients That Cholesterol Drug Zocor Can Cause Muscle Damage
- FDA Adds Black Box Warning About Effectiveness to Label of Blood Thinner Plavix
- Radiation From CT Scans Poses a Special Cancer Risk to Children
- Dialysis Machine Recalled for Potential for Death or Serious Injury
- Senate Investigation of Avandia Shows Manufacturer Knew About Risks Years Ago
- FDA Puts Severe Restrictions on Use of Anemia Drugs in Cancer Patients
- Study Shows Common Antidepressant Lowers Effectiveness of Breast Cancer Drug
- FDA Issues Stronger Warning About Metabolic Problems for Teens Taking Zyprexa
- Study Shows Anti Obesity Drug Raises Risk of Heart Attack or Stroke in Heart Patients
- FDA Expands McNeil OTC Drug Recall, Rebukes Manufacturer for Yearlong Delay
- Reports Find Nursing Homes Use Antipsychotics Off-Label Despite Safety Warnings
- Analysis Finds Antidepressants Have Little or No Benefit for Mild Depression
- FDA Requests Further Studies of Diabetes Drug Due to Reports of Pancreatitis
- New Studies Show CT Scans Cause Tens of Thousands of Cancers Each Year
- FDA Updates Antidepressant Warning Label to Include Risk of Sudden Cardiac Death
- FDA Finds Greater Risk of Fatal Disorder From Certain MRI Drugs With Gadolinium
- Jury in Prempro Trial Awards Illinois Woman $6.3 Million for Link to Breast Cancer
- FDA Calls for New Labeling for Anesthetics Used in Post-Surgery Pain Pumps
- Study Confirms Serious Blood Clot Threat From Anemia Drugs for Cancer Patients
- Gadolinium Lawsuit Against GE Filed in St. Louis Circuit Court
- Diabetes Drug Prescribing Information Revised to Reflect Reports of Kidney Problems
- European Regulators Review Arthritis Drug Safety as FDA Announces New Case of Brain Infection
- Suspected Defects in Power Cords for Medical Devices Spark FDA Investigation
- FDA System for Tracking and Announcing Medical Device Recalls Faulted as Recalls Soar
- FDA Warns Doctors and Parents About Dosage Discrepancy for Liquid Form of Tamiflu
- FDA Orders Black Box Warning for Injected Sedative at Center of Supreme Court Case
- Memo Introduced at Paxil Trial Suggests Drug Company May Have Buried Negative Studies
- Drug Maker Pfizer to Pay Largest Criminal Fine Ever to Settle Allegations of Off Label Marketing
- Scientists Question Findings in Study of Asthma Drugs Funded by Drug Manufacturer
- FDA Announces Investigation Into Reports That Weight-Loss Drug Caused Liver Failure
- Manufacturer Recalls Generic Adderall Because of Oversized Pills Posing Risk of Heart Problems
- FDA Reviewing Data Suggesting Asthma Medication May Cause Heart Problems and Strokes
- Black Box Safety Warning Ordered for Certain Children’s Drugs That Raise Risk of Cancer
- FDA Requires Black Box Warning for Label of Gastrointestinal Drug Reglan
- Merck and Schering-Plough Pay $5.4 Million to Settle Drug Cover-Up Suits
- FDA Adds Black Box Warning to Painkillers Darvon and Darvocet Because of Risk of Fatal Overdose
- Anti-Smoking Drugs Chantix and Zyban Get Black Box Warning About Risk of Suicide and Mental Illness
- FDA Calls for Reduced Maximum Dosage of Common Pain Reliever Acetaminophen
- FDA Seizes Most of Generic Company Caraco's Drugs Due to Manufacturing Mistakes
- FDA Links Zicam to Permanent Sense of Smell Loss -- Other Homeopathic Products Under Scrutiny
- FDA Recommends Suicidal Behavior Precaution for Singulair and Other Asthma Meds
- New FDA Report Associates Liver Failure with Anti-Thyroid Drug
- Analysis Shows Risk of Perforated Stomach or Bowels Rises Sharply With Use of Cancer Drug
- Watchdog Group Asks FDA to Add Warning on Label of Constipation Drug That May Cause Miscarriage
- Heparin-Linked Deaths Spur Fears About Repeat of 2008 Contaminated Prescription Drug Recall
- FDA Announces Safety Recall of Diet Aid Hydroxycut Following Cases of Liver Damage and Death
- Over-the-Counter Painkillers Must Carry Stronger Warnings of Potential Organ Damage, FDA Decides
- FDA Gets Court Order Barring Pharmaceutical Company From Selling Unapproved and Unsafe Drugs
- Congress Considering Restoring Patients’ Ability to File Defective Medical Device Lawsuits
- Psoriasis Medication Removed from U.S. Market After Link to Brain Infection
- Documents Show FDA Repeatedly Overruled Scientists’ Rejections in Menaflex Knee Device Approval
- Congress Considers Legislation to Reverse Supreme Court Decision on Defective Medical Device Lawsuits
- Unsealed Documents Show Pharmaceutical Company Buried Unfavorable Studies on Seroquel
- U.S. Supreme Court Rules FDA Approval Does Not Bar Pharmaceutical Injury Lawsuits
- FDA to Study Effects of TV Ads for Prescription Drugs on Consumers -- Missouri Pharmaceutical Liability Law Firm
- FDA Panel Recommends Davron and Darvocet Be Removed From Market -- St. Louis Defective Prescription Drug Lawyer
- FDA Recalls Dietary Supplement Containing Undeclared Controlled Substance -- St. Louis Dangerous Drug Attorney
- Troubled Missouri Drug Manufacturer Pulls Almost All Products From Market -- Southern Illinois Drug Injury Law Firm
- Prescription Painkiller Recalled Due to Potential for Dangerous Overdose -- St. Louis Dangerous Medication Law Firm
- Defibrillator Lawsuits Against Medtronic Dismissed--Missouri Medical Device Attorney
- Missouri to Receive $18 Million in Zyprexa Lawsuit -- St. Louis Defective Drugs Attorney
- Johnson & Johnson Recalls Duragesic Patch Painkillers Due to Overdose Potential -- Illinois Defective Prescription Drug Lawyer
- Heparin from China found to be contaminated with man-made chemical--defective drug attorney.
- FDA Warns Public to avoid 69 Brands of Dangerous Diet Pills -- Missouri Defective Medication Attorney
- Fluoroquinolone Antibiotics Such as Levequinn and Cipro Carry an Increased Risk of Tendon Rupture--Defective Drug Lawyer
- Two Bowel-Cleansing Drugs Linked to Severe Kidney Injury -- Illinois Dangerous Drugs Attorney
- Avastin Linked to Blood Clots and Cancer Drug According to a Recent Medical Study-- Missouri Defective Drug Law Firm
- Drug Maker Wyeth Under Fire for Use of Ghostwriters -- St. Louis Defective Drug Lawyers
- Cardiologist Warns of Lax FDA Regulations for New Implanted Defibrillator -- St. Louis Defective Medical Device Lawyer
- Advisory Panel Recommends Ban of Two Asthma Drugs- Serevent and Foradil--Defective Drug Lawyer
- Trasylol Dangers Confirmed in Latest Study
- Duragesic Pain Patch Case-Jury Awards Nearly $16.6M in Damages
- Mechanical Heart Pump Recalled
- Artificial Blood Raises Risk of Death, Heart Attack
- Trasylol Supplies Finally Pulled by Bayer
- Canadian Trasylol Study Results Announced
- Top FDA Staff Opposed the Bush Administration's Attempt To Shield Drug Companies
- Fen-Phen Trial Results in $3 Million Jury Verdict
- Pfizer Agrees to Settle Celebrex and Bextra Claims for $894 Million
- Transvaginal Surgical Mesh is the Subject of a FDA Public Health Notification
- Deaths Linked to Anti-Anemia Drugs Probed
- Supreme Court to Decide Appeal Filed by Wyeth against Amputee
- Medtronic Infusion Pump Recalled by the FDA
- Trasylol Pulled From the Market and Can Only be Used for Investigational Use
- Trasylol Pulled From the Market and Can Only be Used for Investigational Use